NSAID-Induced gastroduodenal damage: Is prevention needed?: A review and metaanalysis

Journal of Clinical Gastroenterology

Volumn 17, Issue 3, 1993, Pages 238-243

  Stalnikowicz, Ruth ^a   Rachmilewitz, Daniel ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Mucosal damage; NSAIDs; Protection

Indexed keywords

ACETYLSALICYLIC ACID; CIMETIDINE; IBUPROFEN; INDOMETACIN; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; RANITIDINE; SUCRALFATE; TOLMETIN;

ARTICLE; DUODENUM DISEASE; GASTRODUODENAL ULCER; GASTROINTESTINAL ENDOSCOPY; HEART INFARCTION; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RHEUMATIC DISEASE; STOMACH INJURY; ULCER PERFORATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; GASTRIC MUCOSA; HISTAMINE H2 ANTAGONISTS; HUMAN; INTESTINAL MUCOSA; MISOPROSTOL; PEPTIC ULCER;

EID: 0027361083     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/00004836-199310000-00014     Document Type: Article

References (38)

1. Loludice TA, Saleem T, Lang JA. Cimetidine in the treatment of gastric ulcer induced by steroidal and nonsteroidal anti-inflammatory agents. Am J Gastroenterol 1981;75: 105-9.
2. Caldwell JR, Roth SH, Wu WC, Semble EL, Castell DO, Heller MD. Sucralfate treatment of nonsteroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage. Am J Med [Suppl] 1987;83:74-82.
3. Simon B, Damman HG, Leucht U, Muller P. Ranitidine in the therapy of NSAID-induced gastroduodenal lesions. Results of a randomized, placebo-controlled, double-blind study in patients with rheumatic diseases. Scand J Gastroenterol [Suppl] 1988;23:18-21.
4. Croker JR, Cotton PB, Boyle AC, Kinsella P. Cimetidine for peptic ulcer in patients with arthritis. Ann Rheum Dis 1980;39:275-8.
5. Gerber LH, Rooney PJ, McCarthy DM. Healing of peptic ulcers during continuing anti-inflammatory drug therapy in rheumatoid arthritis. J Clin Gastroenterol 1981;3: 7-11.
6. Berkowitz JM, Adler SN, Sharp JT, Warner CW. Reduction of aspirin-induced gastroduodenal mucosal damage with ranitidine. J Clin Gastroenterol 1986;8:377-80.
7. Lanza FL. A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects. Dig Dis Sci [Suppl] 1986;31:131S-6S.
8. Lanza FL, Peace K, Gustitus L, Rack MF, Dickson B. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirininduced gastric and duodenal ulceration. Am J Gastroenterol 1988;83:143-6.
9. Lanza FL, Aspinall RL, Swabb EA, Davis RE, Rack MF, Rubin A. Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. Gastroenterology 1988;95:289-94.
10. Jiranek GC, Kimmey MB, Saunders DR, Willson RA, Shanahan W, Silverstein FE. Misoprostol reduces gastroduodenal injury from one week of aspirin: an endoscopic study. Gastroenterology 1989;96:656-61.
11. Stalnikowicz R, Goldin E, Fich A, Wengrower D, Eliakim R, Ligumsky M. Indomethacin-induced gastroduodenal damage is not affected by cotreatment with ranitidine. J Clin Gastroenterol 1989;11:178-82.
12. Lanza FL, Fakouhi D, Rubin A, Davis RE, Rack MF, Nissen C. A double-blind placebo-controlled comparison of the efficacy and safety of 50, 100, and 200 μg of misoprostol QID in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms. Am J Gastroenterol 1989;84:633-6.
13. Jaszewski R. Frequency of gastroduodenal lesions in asymptomatic patients on chronic aspirin or nonsteroidal antiinflammatory drug therapy. J Clin Gastroenterol 1990;12:10-3.
14. Silvoso GR, Ivey KJ, Butt JH, Lockard OO, Holt SD, Sisk C. Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. Ann Intern Med 1979;91:517-20.
15. Lockard OO, Ivey KJ, Butt JH, Silvoso GR, Sisk C, Holt SD. The prevalence of duodenal lesions in patients with rheumatic diseases on chronic aspirin therapy. Gastrointest Endosc 1980;26:5-9.
16. Morris AD, Holt SD, Silvoso GR, et al. Effect of antiinflammatory drug administration in patients with rheumatoid arthritis. An endoscopic assessment. Scand J Gastroenterol [Suppl] 1981;16:131-5.
17. Aspirin Myocardial Infarction Study Research Group. A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 1980;243:661-9.
18. Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a veterans administration cooperative study. N Engl J Med 1983;309:396-403.
19. UK-TIA Study Group. United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results. Br Med J 1988;296:316-20.
20. Elwood PC, Sweetnam PM. Aspirin and secondary mortality after myocardial infarction. Lancet 1979;2:1313-5.
21. Somerville K, Faulkner G, Langman M. Non-steroidal antiinflammatory drugs and bleeding peptic ulcer. Lancet 1986;2:462-4.
22. Collier D ST, Pain JA. Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut 1985;26:359-63.
23. Levy M. Aspirin use in patients with major upper gastrointestinal bleeding and peptic-ulcer disease. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. N Engl J Med 1974;290:1158-62.
24. Levy M, Miller DR, Kaufman DW, Siskind V, Schwingl P, Rosenberg L. Major upper gastrointestinal tract bleeding. Relation to the use of aspirin and other nonnarcotic analgesics. Arch Intern Med 1988;148:281-5.
25. Silverstein FE, Kimmey MB, Saunders DR, Levine DS. Gastric protection by misoprostol against 1300 mg of aspirin. An endoscopic study. Dig Dis Sci [Suppl] 1986;31:137-41.
26. Kimmey MB, Silverstein FE, Saunders DR, Chapman RC. Reduction of endoscopically assessed acute aspirin-induced gastric mucosal injury with cimetidine. Dig Dis Sci [Suppl] 1987;32:851-6.
27. Gilbert DA, Surawicz CM, Silverstein FE, Weinberg CR, Saunders DR, Feld AD. Prevention of acute aspirin-induced gastric mucosal injury by 15-R-15 methyl prostaglandin E2: an endoscopic study. Gastroenterology 1984;86:339-5.
28. Stiel D, Ellard KT, Hills LJ, Brooks PM. Protective effect of enprostil against aspirin-induced gastroduodenal mucosal injury in man. Comparison with cimetidine and sucralfate. Am J Med [Suppl] 1986;81:54-8.
29. Aadland E, Fausa O, Vatn M, Cohen H, Quinlan D. Protection by misoprostol against naproxen-induced gastric mucosal damage. Am J Med [Suppl] 1987;83:37-40.
30. Cohen MM, McCready DR, Clark L, Sevelius H. Protection against aspirin-induced antral and duodenal damage with enprostil. A double-blind endoscopic study. Gastroenterology 1985;88:382-6.
31. Tesler MA, Lim ES. Protection of gastric mucosa by sucralfate from aspirin-induced erosions. J Clin Gastroenterol [Suppl] 1981;3:175-9.
32. Stalnikowicz R, Pollak D, Eliakim R, Wengrover D, Fich A, Goldin E. Cimetidine decreases indomethacin induced duodenal mucosal damage in patients with acute musculoskeletal conditions. Gut 1988;29:1578-82.
33. Graham DY, Agrawal NM, Roth SH. Prevention of NSAID-induced gastric ulcer with misoprostol. Multicentre, double-blind, placebo-controlled trial. Lancet 1988;2: 1277-80.
34. Robinson MG, Griffin JW, Bowers J, et al. Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs. Dig Dis Sci 1988;34:424-8.
35. Ehsanullah RS, Page MC, Wood JR. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. Br Med J 1988;297:1017-21.
36. Berkowitz JM, Rogenes PR, Sharp JT, Warner CW. Ranitidine protects against gastroduodenal mucosal damage associated with chronic aspirin therapy. Arch Intern Med 1987;147:2137-9.
37. Fleiss JL. Statistical methods for rates and proportions. New York: John Wiley, 1981.
38. Caruso I, Porro GB. Gastroscopic evaluation of anti-inflammatory agents. Br Med J 1980;280:75-8.